Journal Article10.1615/INTJMEDMUSHROOMS.V18.I7.10
Mushroom Extracts Decrease Bone Resorption and Improve Bone Formation
12
TL;DR: Inhibitory properties of extracts from L. edodes on osteoclasts and the promotion of osteoblasts in vitro, together with the potential to decrease lumbar spine bone loss in an animal osteoporosis model, indicate that medicinal mushroom extracts can be considered as a preventive treatment and/or a supplement to pharmacotherapy to enhance its effectiveness and ameliorate its harmful side effects.
read more
Abstract: Mushroom extracts have shown promising effects in the treatment of cancer and various chronic diseases. Osteoporosis is considered one of the most widespread chronic diseases, for which currently available therapies show mixed results. In this research we investigated the in vitro effects of water extracts of the culinary-medicinal mushrooms Trametes versicolor, Grifola frondosa, Lentinus edodes, and Pleurotus ostreatus on a MC3T3-E1 mouse osteoblast-like cell line, primary rat osteoblasts, and primary rat osteoclasts. In an animal osteoporosis model, rats were ovariectomized and then fed 2 mushroom blends of G. frondosa and L. edodes for 42 days. Bone loss was monitored using densitometry (dual-energy X-ray absorptiometry) and micro computed tomography. In the concentration test, mushroom extracts showed no toxic effect on MC3T3-E1 cells; a dose of 24 µg/mL showed the most proliferative effect. Mushroom extracts of T. versicolor, G. frondosa, and L. edodes inhibited osteoclast activity, whereas the extract of L. edodes increased osteoblast mineralization and the production of osteocalcin, a specific osteoblastic marker. In animals, mushroom extracts did not prevent trabecular bone loss in the long bones. However, we show for the first time that the treatment with a combination of extracts from L. edodes and G. frondosa significantly reduced trabecular bone loss at the lumbar spine. Inhibitory properties of extracts from L. edodes on osteoclasts and the promotion of osteoblasts in vitro, together with the potential to decrease lumbar spine bone loss in an animal osteoporosis model, indicate that medicinal mushroom extracts can be considered as a preventive treatment and/or a supplement to pharmacotherapy to enhance its effectiveness and ameliorate its harmful side effects.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Bioactive components of mushrooms: Processing effects and health benefits.
TL;DR: In this article, a review of the literature on the nutritional, nutraceutical, and therapeutic potential of mushrooms, and their use as functional foods for the maintenance of health was reviewed, and the available literature indicates the enormous potential of the bioactive compounds present in mushrooms.
121
Examining the health effects and bioactive components in Agaricus bisporus mushrooms: a scoping review.
Michelle Blumfield,Kylie A. Abbott,Emily Duve,Tim Cassettari,Skye Marshall,Flavia Fayet-Moore +5 more
TL;DR: Beneficial effects of A. bisporus on metabolic syndrome, immune function, gastrointestinal health and cancer, with the strongest evidence for the improvement in Vitamin D status in humans, were found.
Phytoconstituents as novel osteo-protective agents: Implications in bone health.
Zaffar Azam,Vikas Pandey,Navita Gupta,Leena Sapra,Hamid Y. Dar,Niti Shokeen,Vandana Soni,Rupesh K. Srivastava +7 more
TL;DR: This review is an attempt for the first time to collectively document the therapeutic properties of valuable medicinal plants in preventing and treating bone loss in osteoporosis.
23
Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression.
Hyerim Lee,Kyubin Lee,Sheunghun Lee,Jisu Lee,Won Tae Jeong,Heung Bin Lim,Tae Kyung Hyun,Sun-Ju Yi,Kyunghwan Kim +8 more
TL;DR: It is shown that an ethyl acetate fraction from the shiitake mushroom, Lentinula edodes, inhibited RANKL-induced osteoclast differentiation by blocking the NFATc1 signaling pathway, and treatment of LEA rescued an osteoporotic phenotype in a zebrafish model of glucocorticoid-induced arthritis.
14
UV and Chemically Induced Halomonas smyrnensis Mutants for Enhanced Levan Productivity.
TL;DR: In this paper , the authors aimed at increasing levan productivity of H. smyrnensis AAD6T cultures using random mutagenesis techniques combined (i.e., ethyl methanesulfate treatment and/or ultraviolet irradiation).
11
References
•Journal Article
[Calcium supplementation in healthy subjects: benefits and risks].
Michael Drozd,Klaus K. Witte +1 more
TL;DR: The aim of this review is summarise recent data demonstrating elevated cardiovascular risk possibly attributable to oral calcium supplementation in healthy individuals.
2
Thyroid‐Stimulating Hormone Restores Bone Volume, Microarchitecture, and Strength in Aged Ovariectomized Rats*
T. Kuber Sampath,Petra Simic,Rebecca Sendak,Nataša Drača,Ann E. Bowe,Stephen J. O'Brien,Susan C. Schiavi,John M. McPherson,Slobodan Vukicevic +8 more
TL;DR: It is shown the systemic administration of low levels of TSH increases bone volume and improves bone microarchitecture and strength in aged OVX rats, suggesting TSH directly affects bone remodeling in vivo.
Osteoclast-forming suppressing compounds, gargalols A, B, and C, from the edible mushroom Grifola gargal
Jing Wu,Jae-Hoon Choi,Miyuki Yoshida,Hirofumi Hirai,Etsuko Harada,Kikuko Masuda,Tomoyuki Koyama,Kazunaga Yazawa,Keiichi Noguchi,Kazuo Nagasawa,Hirokazu Kawagishi +10 more
TL;DR: Three novel sterols, gargalols A−C (1−3), and four known sterols (4, 5, 6, and 7) from Grifola gargal were identified by the interpretation of spectroscopic data.
Systemically Administered Bone Morphogenetic Protein-6 Restores Bone in Aged Ovariectomized Rats by Increasing Bone Formation and Suppressing Bone Resorption
Petra Simic,Jasminka Buljan Culej,Iva Orlić,Lovorka Grgurevic,Nataša Drača,Radan Spaventi,Slobodan Vukicevic +6 more
TL;DR: It is shown, for the first time, that systemically administered BMP-6 restores the bone inductive capacity, microarchitecture, and quality of the skeleton in osteoporotic rats.